Valuation: PolyPid Ltd.

Market Cap 9.59Cr 8.52Cr 7.9Cr 7.19Cr 14Cr 909.89Cr 14Cr 95Cr 37Cr 474.82Cr 36Cr 35Cr 1.51TCr P/E 2026 *
-5.3x
P/E 2027 * -3.85x
Enterprise Value 9.59Cr 8.52Cr 7.9Cr 7.19Cr 14Cr 909.89Cr 14Cr 95Cr 37Cr 474.82Cr 36Cr 35Cr 1.51TCr EV / Sales 2026 *
6.39x
EV / Sales 2027 * 11.1x
Free-Float
87.66%
Yield 2026 *
-
Yield 2027 * -
1 day-3.67%
1 week-6.90%
Current month-10.44%
1 month-6.16%
3 months-12.10%
6 months-0.42%
Current year+8.76%
1 week 4.61
Extreme 4.61
5.1
1 month 4.61
Extreme 4.61
5.55
Current year 3.65
Extreme 3.65
5.73
1 year 3.1
Extreme 3.1
5.73
3 years 2.3
Extreme 2.3
9.2
5 years 2.3
Extreme 2.3
257.1
10 years 2.3
Extreme 2.3
583.5
Manager TitleAgeSince
Chief Executive Officer 52 01/07/2022
Director of Finance/CFO 39 -
Chief Tech/Sci/R&D Officer 61 18/08/2025
Director TitleAgeSince
Director/Board Member 84 01/04/2008
Director/Board Member 52 08/08/2022
Director/Board Member 74 01/12/2018
Date Insider Type Main position Quantity % Market Cap. Importance
15/07/26 Free

Director

9,132 0.0896%
15/07/26 Free

Director

9,132 0.0896%
15/07/26 Free

Chairman

9,132 0.0896%
Change 5-day change 1-year change 3-year change Capi.($)
-3.67%-6.90%+44.34%+21.03% 9.59Cr
+0.43%+6.59%+56.57%+106.64% 1,12000Cr
+0.90%-2.25%+32.26%+63.73% 62TCr
+0.71%+3.24%+24.33%+91.33% 50TCr
-0.13%+5.98%+33.66%+50.18% 37TCr
+0.52%+0.24%+72.13%+40.11% 36TCr
-0.95%+4.70%+19.65%+42.71% 29TCr
-1.98%+3.73%-0.89%+10.43% 26TCr
-0.35%+4.25%+44.74%+52.06% 23TCr
-0.75%+3.32%+27.18%+94.07% 19TCr
Average -0.53%+2.56%+35.40%+57.23% 39.41TCr
Weighted average by Cap. +0.13%+3.83%+39.34%+71.82%

Financials

2026 *2027 *
Net sales 1.5Cr 1.33Cr 1.24Cr 1.12Cr 2.12Cr 142.36Cr 2.16Cr 15Cr 5.82Cr 74Cr 5.63Cr 5.51Cr 236.82Cr 86.75L 77.11L 71.47L 65.03L 1.23Cr 82Cr 1.25Cr 8.59Cr 3.37Cr 43Cr 3.26Cr 3.19Cr 136.96Cr
Net income -2Cr -1.78Cr -1.65Cr -1.5Cr -2.83Cr -190.06Cr -2.88Cr -20Cr -7.78Cr -99Cr -7.52Cr -7.36Cr -316.18Cr -3.15Cr -2.8Cr -2.6Cr -2.36Cr -4.46Cr -299.43Cr -4.53Cr -31Cr -12Cr -156.25Cr -12Cr -12Cr -498.12Cr
Net Debt - -
Projected Income Statement - Annual - PolyPid Ltd.
Logo PolyPid Ltd.
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
Employees
72
Date Price Change Volume
16/26/16 $4.720 -3.67% 1,50,736
15/26/15 $4.900 +1.45% 1,20,601
14/26/14 $4.830 -1.02% 1,33,083
13/26/13 $4.880 -2.79% 93,370
12/26/12 $5.020 -0.99% 77,636
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - PolyPid Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.720USD
Average target price
11.75USD
Spread / Average Target
+148.94%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PolyPid Ltd.
  1. Stock Market
  2. Stocks
  3. PYPD Stock